Cagrilintide.

Cagrilintide is a long-acting amylin analog with a fatty acid side chain. With the molecular formula C₁₉₀H₂₉₇N₅₁O₅₈ and a molecular weight of 4220.8 g/mol (CAS: 1417329-69-3), it structurally mimics e...

$62.00

Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for Cagrilintide.

Receptor interaction

Amylin Receptors (AMY)

Published research demonstrates Cagrilintide modulates targeted signaling cascades within cell tissue models.

Signaling cascade

Calcitonin Receptors

In cellular environments, Cagrilintide exhibits selective binding and corresponding pathway activation.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on Cagrilintide molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of Cagrilintide in standardized assay systems.

Preclinical

Cagrilintide structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of Cagrilintide in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring